"10.1371_journal.pbio.1001433","plos biology","2012-11-27T00:00:00Z","Sona Kang; Peter Akerblad; Riku Kiviranta; Rana K Gupta; Shingo Kajimura; Michael J Griffin; Jie Min; Roland Baron; Evan D Rosen","Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; AstraZeneca R&D Mölndal, Mölndal, Sweden; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, and Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Department of Cancer Biology and Division of Metabolism and Chronic Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America","The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: SoK EDR RB RK ShK RG MG PA. Performed the experiments: SoK RK MG JM. Analyzed the data: SoK RK EDR RB. Contributed reagents/materials/analysis tools: RK RB MG. Wrote the paper: EDR SoK.","One author (PA) is employed by a commercial entity (AstraZeneca), but there are no restrictions put by this company to publish this work or make data or materials available.","2012","11","Sona Kang","SK",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
